Marca Nominativa depositada no INPI em 12/07/2024 por Prothena Biosciences Limited, processo nº 501807645, nas classes 05, 42, 45. Registro em vigor até 12/07/2034.
| Número do processo | 501807645 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Nominativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 12/07/2024 |
| Data da concessão | 27/01/2026 |
| Vigência até | 12/07/2034 |
| Titular | Prothena Biosciences Limited |
| UF · País | — · IE |
Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes.;
Research and development in the pharmaceutical and biotechnology fields.;
Licensing of intellectual property in the field of biotechnology.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501807645 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas3 despacho(s) publicado(s) na Revista da Propriedade Industrial.